Regulation of T cell activation and tolerance by Grail
Regulation of T cell activation and tolerance by Grail
批准号:
8068904
负责人:
Roza Insafetdinovna Nurieva
金额:
$37.73万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2014-05-31
关键词:
Antigen-Presenting CellsAutoimmune DiseasesAutoimmune ResponsesAutoimmunityCD28 geneCD4 Positive T LymphocytesCell physiologyCellsDefectDevelopmentEnsureGene ExpressionGenerationsGenesIn VitroInterleukin-17InvadedKnockout MiceKnowledgeLeadLymphocyteLymphocyte ActivationLymphocyte FunctionModelingPeripheralPredispositionRegulationRegulatory T-LymphocyteRoleSignal TransductionT cell anergyT cell regulationT-Cell ActivationT-LymphocyteTissuesTransducersX Chromosomeabstractinganergyextracellulargene functiongene repressionimmune functionimmune self tolerancein vivoinsightmutant mouse modelnovelpathogenperipheral tolerancepublic health relevancetranscription factorubiquitin-protein ligase
中文摘要
描述(由申请人提供):摘要T淋巴细胞的激活受到严格的调控,以确保有效地清除入侵的病原体,同时保持对自身组织的耐受性。T细胞一方面受细胞外信号的调节,尤其是抗原提呈细胞上的正负共刺激分子,另一方面也受微妙的细胞内信号转导和调节因子的调节。最近,我们发现在没有CD28和ICOS共刺激的情况下被激活的T细胞变得无功能和无反应,支持共刺激在T细胞激活中的关键作用。这些耐受T细胞不仅在TCR信号转导方面存在严重缺陷,而且完全缺乏效应特异性转录因子的表达。有趣的是,GRAIL(与淋巴细胞无能相关的基因)只有在CD28和ICOS信号都缺失的情况下才在T细胞中表达上调。GRAIL是一种E3泛素连接酶,其表达与体内和体外的CD4T细胞无能有关。阻断负的共刺激信号(B7S1、B7-H3或PD-1)可恢复T细胞功能,这与效应器特异性转录因子的表达和GRAIL的表达下调有关。为了确定GRAIL在T细胞活化和耐受中的作用,我们建立了GRAIL突变小鼠模型。我们发现Grail缺陷T细胞在体外的激活和效应分化过程中并不依赖于CD28和ICOS信号。我们目前研究的中心假设是,Grail分子对T细胞的耐受性和功能起着关键的调节作用。我们将首先分析GRAIL在外周T细胞耐受中的作用。此外,我们还将确定GRAIL调节T细胞耐受的机制。其次,我们将分析Grail在自然和可诱导Treg细胞的产生和功能中的作用。最后,我们将评估圣杯缺乏是否会导致自身免疫性疾病的易感性,以及这是否由NA和/或Treg细胞缺陷引起。这些拟议的研究将极大地促进我们对Grail在外周耐受和自身免疫反应中的作用的了解。
公共卫生相关性:T淋巴细胞的激活受到严格控制,以确保有效地消除入侵病原体,并保持对自身组织的耐受性。T细胞一方面受细胞外信号的调节,尤其是抗原提呈细胞上的正负共刺激分子,另一方面也受微妙的细胞内信号转导和调节因子的调节。我们对Grail基因敲除小鼠的初步分析揭示了它在体外诱导T细胞耐受中的基本功能。在本项目中,我们建议继续分析Grail在体外和体内T细胞中的功能。这些拟议的研究将极大地促进我们对T细胞中Grail功能的了解,并将为调节自身耐受和免疫功能的T细胞调节提供新的和独特的见解。
英文摘要
DESCRIPTION (provided by applicant): Abstract T lymphocyte activation is tightly regulated to ensure effective elimination of invading pathogens as well as maintaining tolerance against self-tissues. On one hand, T cells are regulated by extracellular signals, especially the positive and negative costimulatory molecules on antigen-presenting cells, and on the other hand, also by delicate intracellular signal transducers and regulators. Recently, we found that T cells activated in the absence of both CD28 and ICOS costimulation became nonfunctional and nonresponsive, supporting a critical role of costimulation in T cell activation. These tolerant T cells not only were anergic with profound defects in TCR signal transduction but also completely lacked expression of effector-specific transcription factors. Interestingly, expression of Grail (gene related to anergy in lymphocytes), was only upregulated in T cells when both CD28 and ICOS signaling were absent. Grail is an E3 ubiquitin ligase whose expression was previously found to be associated with CD4 T cell anergy in vitro and in vivo. Blocking of negative costimulatory signals (B7S1, B7-H3 or PD-1) restored T cell function, associated with expression of effector-specific transcription factors and down-regulation of Grail expression. To determine the function of Grail in T cell activation and tolerance, we developed a Grail mutant mouse model. We found that Grail-deficient T cells were not dependent on CD28 and ICOS signaling in activation and effector differentiation in vitro. Our central hypothesis for the current study is that Grail molecule critically regulates T cell tolerance and function. We will first analyze the role of Grail in peripheral T cell tolerance. In addition, we will determine the mechanisms whereby Grail regulates T cell tolerance. Secondly, we will analyze the function of Grail in generation and function of natural and inducible Treg cells. Lastly, we will assess whether Grail deficiency will lead to susceptibility to autoimmune diseases and whether this is caused by defects in na¿ve and/or Treg cells. These proposed studies will greatly advance our knowledge on Grail function in peripheral tolerance and autoimmune responses.
PUBLIC HEALTH RELEVANCE: T lymphocyte activation is tightly regulated to ensure effective elimination of invading pathogens as well as maintaining tolerance against self-tissues. On one hand, T cells are regulated by extracellular signals, especially the positive and negative costimulatory molecules on antigen-presenting cells, and on the other hand, also by delicate intracellular signal transducers and regulators. Our preliminary analysis of a Grail knockout mouse revealed its essential function in induction of T cell tolerance in vitro. In this project, we propose to continue our analysis on function of Grail in T cells in vitro and in vivo. These proposed studies will greatly advance our knowledge on Grail function in T cells and will provide a novel and unique insight into proper T cell regulation that governs self tolerance and immune function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
-
批准号:10753628
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2023
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
-
批准号:10311074
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2019
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of Cul4A in Governing Th2-Type Tolerance
-
批准号:10198025
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2018
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of Cul4A in Governing Th2-Type Tolerance
-
批准号:9770641
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2018
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Grail-targeting breaks the immune tolerance to melanoma
-
批准号:9379209
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2017
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
STAT1: New regulator of inflammatory Th17 and Th2 cells
-
批准号:9112386
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2016
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
STAT1: New regulator of inflammatory Th17 and Th2 cells
-
批准号:9206467
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2016
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Role of Grail in maintaining humoral immune tolerance
-
批准号:9089880
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2015
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:8468985
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:7869435
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:7700519
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
Regulation of T cell activation and tolerance by Grail
-
批准号:8277281
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2009
-
负责人:Roza Insafetdinovna Nurieva
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: